These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunologic response to EIAV offers hope for AIDS treatment. Kahler S J Am Vet Med Assoc; 1992 Dec; 201(11):1672-3. PubMed ID: 1338067 [No Abstract] [Full Text] [Related]
3. Immunopathogenesis of equine infectious anemia lentivirus disease. McGuire TC; O'Rourke KI; Perryman LE Dev Biol Stand; 1990; 72():31-7. PubMed ID: 2178127 [TBL] [Abstract][Full Text] [Related]
5. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection. Mealey RH; Leib SR; Pownder SL; McGuire TC J Virol; 2004 Sep; 78(17):9295-305. PubMed ID: 15308724 [TBL] [Abstract][Full Text] [Related]
6. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses. Taylor SD; Leib SR; Carpenter S; Mealey RH J Virol; 2010 Jul; 84(13):6536-48. PubMed ID: 20392850 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocytes in protection against equine infectious anemia virus. McGuire TC; Fraser DG; Mealey RH Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338 [TBL] [Abstract][Full Text] [Related]
8. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern. Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100 [TBL] [Abstract][Full Text] [Related]
9. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus. O'Rourke KI; Perryman LE; McGuire TC Vet Immunol Immunopathol; 1989 Nov; 23(1-2):41-9. PubMed ID: 2559537 [TBL] [Abstract][Full Text] [Related]
10. Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy. Mealey RH; Littke MH; Leib SR; Davis WC; McGuire TC Vet Immunol Immunopathol; 2008 Jan; 121(1-2):8-22. PubMed ID: 17727961 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency. Taylor SD; Leib SR; Wu W; Nelson R; Carpenter S; Mealey RH J Virol; 2011 Jul; 85(13):6814-8. PubMed ID: 21543497 [TBL] [Abstract][Full Text] [Related]
12. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012 [TBL] [Abstract][Full Text] [Related]
13. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection. Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160 [TBL] [Abstract][Full Text] [Related]
14. Responses in horses infected with equine infectious anemia virus adapted to tissue culture. Gutekunst DE; Becvar CS Am J Vet Res; 1979 Jul; 40(7):974-7. PubMed ID: 228570 [No Abstract] [Full Text] [Related]